Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy

Annals of Nuclear Medicine

Volumn 22, Issue 1, 2008, Pages 79-82

  Yang, Ji Gang ^a   Li, Chun Lin ^a   Hao, Rui Rui ^a   Zou, Lan Fang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Osteogenic sarcoma of breast; Tc 99m MDP; Tc 99m MIBI

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BONE SCINTISCANNING; BREAST SARCOMA; CANCER DIAGNOSIS; CASE REPORT; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; LYMPH NODE DISSECTION; MASTECTOMY; OSTEOSARCOMA; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY;

BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OSTEOSARCOMA; RADIOPHARMACEUTICALS; RARE DISEASES; TECHNETIUM TC 99M MEDRONATE; TECHNETIUM TC 99M SESTAMIBI;

EID: 38849198511     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0074-3     Document Type: Article

References (27)

1. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
2. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. In vitro update of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993;34:1949-1952.
3. Melloul M, Paz A, Ohana G, Laver O, Michalevich D, Koren R, et al. Double-phase 99m Tc-sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med 1999;40:376-380.
4. Maini L, de Notaristefani F, Tofani A, Lacopi F, Scjuto R, Semprebene A, et al. 99m Tc-MIBI scintimammography using a dedicated nuclear mammography. J Nucl Med 1999;40:46-51.
5. Thrall J, Ziessman H, editors. The requisites nuclear medicine. St. Louis: Mosby; 2001. p. 36-39.
6. Schwartz Z, Shanj J, Soskolne WA, Touma H, Amir D, Sela J. Uptake and biodistribution of technetium-99m-MDP during rat tibial bone repair. J Nucl Med 1993;34:104-108.
7. Zucker I, Charkes ND, Seidmon EJ, Maurer AH. Soft-tissue uptake of technetium-99m-MDP after prostate cryoablation. J Nucl Med 1997;38:525-528.
8. Ergun EL, Ceylan E. Soft tissue uptake observed on Tc-99m MDP bone scans: rare imaging patterns in two cases. Clin Nucl Med 2001;26:958-959.
9. Loutfi I, Collier BD, Mohammed AM. Nonosseous abnormalities on bone scans. J Nucl Med Technol 2003;31:149-153.
10. Papantoniou V, Sotiropoulou M, Stipsaneli E, Louvrou A, Feda H, Christodoulidou J, et al. Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: value of Tc-99m (V)DMSA. Clin Nucl Med 2000;25:434-439.
11. Papantoniou V, Christodoulidou J, Papadaki E, Louvrou A, Feda H, Christodoulidou J, et al. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI. Eur J Nucl Med 2001;28:923-928.
12. Palmedo H, Hensel J, Reinhardt M, Von Mallek D, Matthies A, Biersack HJ. Breast cancer imaging with PET and SPECT agents: an in vivo comparison. Nucl Med Biol 2002;29:809-815.
13. Ali I, Johns W, Gupta SM. Visualization of hepatic metastases of medullary thyroid carcinoma on Tc-99m MDP bone scintigraphy. Clin Nucl Med 2006;31:611-613.
14. Mariani G. Unexpected keys in cell biochemistry imaging: some lessons from technetium-99m-sestamibi. J Nucl Med 1996;37:536-538.
15. Taki J, Sumiya H, Asada N, Ueda Y, Tsuchiya H, Tonami N. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. J Nucl Med 1998;39:1179-1184.
16. Schmidt E, Kett K, Anga B, Bodis J, Zambo K. Diagnostic value of 99mTc-methoxy-isobutyl-isonitril and 99mTc-methylene diphosphonate scintimammography in the preoperative evaluation of breast cancer. Orv Hetil 2003;144:787-792.
17. Ozcan Z, Burak Z, Erinc R, Dirlik A, Basdemir G, Sabah D, et al. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours. Nucl Med Commun 2001;22:679-683.
18. Cancer B, Kitapcl M, Unlu M, Erbengi G, Calikoglu T, Gogus T, et al. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP. J Nucl Med 1992;33:319-324.
19. Alexandrakis MG, Kyriakou DS, Passam F, Koukouraki S, Karkavitsas N. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate. Ann Hematol 2001;80:349-353.
20. McPherson K, Steel CM, Dixon JM. ABC of breast diseases, breast cancer epidemiology, risk factors, and genetics. BMJ 2000;321:624-628.
21. Shimazu K, Funata N, Yamamoto Y, Mori T. Primary osteosarcoma arising in the colon: report of a case. Dis Colon Rectum 2001;44:1367-1370.
22. Minami H, Wakita N, Kawanishi Y, Kitano I, Sakata M, Shida T. Primary osteosarcoma of heart with severe congestive heart failure. Jpn J Thorac Cardiovasc Surg 2000;48:607-609.
23. Lee JS, Choi YD, Choi C. Primary testicular osteosarcoma with hydrocele. Virchows Arch 2004;445:210-213.
24. Olgyai G, Horvath V, Kocsis J, Buza N, Olah A. Extraskeletal osteosarcoma in the gallbladder. Magy Seb 2003;56:57-60.
25. Oluwasola AO, Adebamowo CA, Ezeome ER, Oduntan O, Akang EE. Osteogenic sarcoma of the breast: case report of a diagnostic dilemma. Afr J Med Med Sci 2000;30:129-131.
26. Hosoi H, Yoshioka M, Tanaka Y, Wada I, Nakao M, Maeda S, et al. Primary osteogenic sarcoma of the breast: report of a case. Nippon Geka Gakkai Zasshi 1989;90:1262-1265.
27. Roebuck DJ, Salo JK, Fahmy J. Breast metastases in osteosarcoma. Aust Radiol 1999;43:108-110.